These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34042517)

  • 1. Biobanking of Specimens from COVID-19 Patients: An Economic Perspective from a Clinical Biobank.
    Niedermair T; Bhatt M; Wallner S; Babel M; Burkhardt R; Brochhausen C
    Biopreserv Biobank; 2021 Oct; 19(5):453-456. PubMed ID: 34042517
    [No Abstract]   [Full Text] [Related]  

  • 2. A Study of Policies and Guidelines for Collecting, Processing, and Storing Coronavirus Disease 2019 Patient Biospecimens for Biobanking and Research.
    Gao F; Tao L; Ma X; Lewandowski D; Shu Z
    Biopreserv Biobank; 2020 Dec; 18(6):511-516. PubMed ID: 33290126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biobanking for COVID-19 research.
    Rovere-Querini P; Tresoldi C; Conte C; Ruggeri A; Ghezzi S; DE Lorenzo R; DI Filippo L; Farina N; Ramirez GA; Ripa M; Mancini N; Cantarelli E; Galli L; Poli A; DE Cobelli F; Bonini C; Manfredi AA; Franchini S; Spessot M; Carlucci M; Dagna L; Scarpellini P; Ambrosio A; DI Napoli D; Bosi E; Tresoldi M; Lazzarin A; Landoni G; Martino G; Zangrillo A; Poli G; Castagna A; Vicenzi E; Clementi M; Ciceri F;
    Panminerva Med; 2022 Jun; 64(2):244-252. PubMed ID: 33073557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A retrospective safety study on screening of the samples in the clinical biobank of Beijing Hospital].
    Li HX; Tang XK; Xu SY; Luo XM; Sun GY; Xu HT; Zhang PJ; Xiao F
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Sep; 55(9):1149-1152. PubMed ID: 34619936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Insights from creating a covid-19 biobank in Sweden].
    Ljunggren HG; Strålin K; Chen P; Cornillet M; Rooijackers O; I Eriksson L; Aleman S; Björkström N
    Lakartidningen; 2021 Dec; 118():. PubMed ID: 34910294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Data Sharing Solutions for Biobanks for the COVID-19 Pandemic.
    Paul S; Chatterjee MK
    Biopreserv Biobank; 2020 Dec; 18(6):581-586. PubMed ID: 32833506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biobanking in the COVID-19 Era and Beyond: Part 2. A Set of Tool Implementation Case Studies.
    Allocca CM; Snapes E; Albert M; Bledsoe MJ; Castelhano MG; De Wilde M; Furuta K; Kozlakidis Z; Martin D; Martins A; McCall SJ; Schacter B
    Biopreserv Biobank; 2020 Dec; 18(6):547-560. PubMed ID: 33226280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Responses of Biobanks to COVID-19.
    Henderson MK; Kozlakidis Z; Fachiroh J; Wiafe Addai B; Xu X; Ezzat S; Wagner H; Marques MMC; Yadav BK
    Biopreserv Biobank; 2020 Dec; 18(6):483-491. PubMed ID: 32871085
    [No Abstract]   [Full Text] [Related]  

  • 9. Opportunities and Risks for Research Biobanks in the COVID-19 Era and Beyond.
    Simeon-Dubach D; Henderson MK
    Biopreserv Biobank; 2020 Dec; 18(6):503-510. PubMed ID: 33047969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pandemics: global biobanking for equitable testing.
    Basile AJ; Hampton LM
    Nature; 2020 Nov; 587(7833):197. PubMed ID: 33173224
    [No Abstract]   [Full Text] [Related]  

  • 11. Biobanking During the COVID-19 Pandemic.
    Vaught J
    Biopreserv Biobank; 2020 Jun; 18(3):153-154. PubMed ID: 32297797
    [No Abstract]   [Full Text] [Related]  

  • 12. Response to 'Multimorbidity and SARS-CoV-2 infection in UK biobank'.
    Sur Roy A; Joshi A
    Diabetes Metab Syndr; 2020; 14(5):969. PubMed ID: 32604017
    [No Abstract]   [Full Text] [Related]  

  • 13. Possible consequences of the COVID-19 pandemic on the use of biospecimens from cancer biobanks for research in academia and bioindustry.
    Hofman P; Puchois P; Brest P; Lahlou H; Simeon-Dubach D
    Nat Med; 2020 Jun; 26(6):809-810. PubMed ID: 32382152
    [No Abstract]   [Full Text] [Related]  

  • 14. Commentary: APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort.
    Kasparian K; Graykowski D; Cudaback E
    Front Immunol; 2020; 11():1939. PubMed ID: 33042114
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to 'Vitamin D concentrations and COVID-19 infection in UK Biobank'.
    Roy AS; Matson M; Herlekar R
    Diabetes Metab Syndr; 2020; 14(5):777. PubMed ID: 32526626
    [No Abstract]   [Full Text] [Related]  

  • 16. ApoE e4e4 Genotype and Mortality With COVID-19 in UK Biobank.
    Kuo CL; Pilling LC; Atkins JL; Masoli JAH; Delgado J; Kuchel GA; Melzer D
    J Gerontol A Biol Sci Med Sci; 2020 Sep; 75(9):1801-1803. PubMed ID: 32623451
    [No Abstract]   [Full Text] [Related]  

  • 17. Establishment of a Collection of Blood-Derived Products from COVID-19 Patients for Translational Research: Experience of the LPCE Biobank (Nice, France).
    Tanga V; Leroy S; Fayada J; Hamila M; Allegra M; Messaoudi Z; Bonnetaud C; Lespinet V; Bordone O; Washetine K; Griffonnet J; Maniel C; Philibert L; Selva E; Benzaquen J; Ilie M; Long E; Lassalle S; Lantéri E; Marquette CH; Hofman V; Hofman P
    Biopreserv Biobank; 2020 Dec; 18(6):517-524. PubMed ID: 33175565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reply to letter of Davie et al. regarding the article: "Vitamin D concentrations and COVID-19 infection in UK Biobank" (Hastie et al.).
    Pell JP; Hastie CE; Sattar N
    Diabetes Metab Syndr; 2021; 15(2):642. PubMed ID: 33663970
    [No Abstract]   [Full Text] [Related]  

  • 19. Comment on "ApoE e4e4 Genotype and Mortality With COVID-19 in UK Biobank" by Kuo et al.
    Nikogosov DA; Shevlyakov AD; Baranova AV
    J Gerontol A Biol Sci Med Sci; 2020 Oct; 75(11):2233-2234. PubMed ID: 32803253
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter in response to the article: Vitamin D concentrations and COVID-19 infection in UK biobank (Hastie et al.).
    Grant WB; McDonnell SL
    Diabetes Metab Syndr; 2020; 14(5):893-894. PubMed ID: 32563941
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.